Filed: 8/14/2023ACC: 0001172661-23-003165
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $510.83M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$510.83M
Total AUM (reported)
56.32M
Total Shares
Allocation by class
COM$420.66M82.3%
CLASS A ORD SHS$27.02M5.3%
COM NEW$22.63M4.4%
ADS$17.81M3.5%
SHS$12.88M2.5%
SPONSORED ADS$8.64M1.7%
COMMON STOCK$1.19M0.2%
Portfolio Concentration
Top 3$95.25M18.6%
4–10$173.87M34.0%
11–25$192.09M37.6%
Rest$49.61M9.7%
Top 3 weight
18.6%
Top 10 weight
52.7%
Voting Authority Distribution
Total shares with voting rights: 56.32M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
56.32M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other38
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings38
Rows:
ALPINE IMMUNE SCIENCES INC
DFNDShares3.36M
TypeSH
Market value$34.58M
6.77%
Sole
0.00
Shared
3.36M
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares677.43K
TypeSH
Market value$31.25M
6.12%
Sole
0.00
Shared
677.43K
None
0.00
VAXCYTE INC
DFNDShares589.21K
TypeSH
Market value$29.43M
5.76%
Sole
0.00
Shared
589.21K
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares1.55M
TypeSH
Market value$28.09M
5.50%
Sole
0.00
Shared
1.55M
None
0.00
RAPT THERAPEUTICS INC
DFNDShares1.47M
TypeSH
Market value$27.40M
5.36%
Sole
0.00
Shared
1.47M
None
0.00
POINT BIOPHARMA GLOBAL INC
DFNDShares3M
TypeSH
Market value$27.18M
5.32%
Sole
0.00
Shared
3M
None
0.00
ZURA BIO LTD
DFNDShares3.29M
TypeSH
Market value$27.02M
5.29%
Sole
0.00
Shared
3.29M
None
0.00
ACLARIS THERAPEUTICS INC
DFNDShares2.20M
TypeSH
Market value$22.78M
4.46%
Sole
0.00
Shared
2.20M
None
0.00
AMYLYX PHARMACEUTICALS INC
DFNDShares968.79K
TypeSH
Market value$20.90M
4.09%
Sole
0.00
Shared
968.79K
None
0.00
XENON PHARMACEUTICALS INC
DFNDShares532.70K
TypeSH
Market value$20.51M
4.01%
Sole
0.00
Shared
532.70K
None
0.00
CYTOKINETICS INC
DFNDShares600K
TypeSH
Market value$19.57M
3.83%
Sole
0.00
Shared
600K
None
0.00
ANAPTYSBIO INC
DFNDShares894.33K
TypeSH
Market value$18.19M
3.56%
Sole
0.00
Shared
894.33K
None
0.00
IMMUNOCORE HLDGS PLC
DFNDShares297.08K
TypeSH
Market value$17.81M
3.49%
Sole
0.00
Shared
297.08K
None
0.00
EVOLUS INC
DFNDShares2.43M
TypeSH
Market value$17.70M
3.46%
Sole
0.00
Shared
2.43M
None
0.00
AEROVATE THERAPEUTICS INC
DFNDShares932.16K
TypeSH
Market value$15.99M
3.13%
Sole
0.00
Shared
932.16K
None
0.00
SAREPTA THERAPEUTICS INC
DFNDShares123.60K
TypeSH
Market value$14.15M
2.77%
Sole
0.00
Shared
123.60K
None
0.00
ALKERMES PLC
DFNDShares411.45K
TypeSH
Market value$12.88M
2.52%
Sole
0.00
Shared
411.45K
None
0.00
RHYTHM PHARMACEUTICALS INC
DFNDShares772K
TypeSH
Market value$12.73M
2.49%
Sole
0.00
Shared
772K
None
0.00
OPTINOSE INC
DFNDShares8.84M
TypeSH
Market value$10.87M
2.13%
Sole
0.00
Shared
8.84M
None
0.00
VIKING THERAPEUTICS INC
DFNDShares598.55K
TypeSH
Market value$9.70M
1.90%
Sole
0.00
Shared
598.55K
None
0.00
MINERALYS THERAPEUTICS INC
DFNDShares546.06K
TypeSH
Market value$9.31M
1.82%
Sole
0.00
Shared
546.06K
None
0.00
AMICUS THERAPEUTICS INC
DFNDShares701.39K
TypeSH
Market value$8.81M
1.72%
Sole
0.00
Shared
701.39K
None
0.00
GRACELL BIOTECHNOLOGIES INC
DFNDShares2.27M
TypeSH
Market value$8.64M
1.69%
Sole
0.00
Shared
2.27M
None
0.00
APELLIS PHARMACEUTICALS INC
DFNDShares94.70K
TypeSH
Market value$8.63M
1.69%
Sole
0.00
Shared
94.70K
None
0.00
RENEO PHARMACEUTICALS INC
DFNDShares1.08M
TypeSH
Market value$7.11M
1.39%
Sole
0.00
Shared
1.08M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ALPINE IMMUNE SCIENCES INCDFND | COM | 3.36M | SH | $34.58M 6.77% | 0.00 | 3.36M | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 677.43K | SH | $31.25M 6.12% | 0.00 | 677.43K | 0.00 |
VAXCYTE INCDFND | COM | 589.21K | SH | $29.43M 5.76% | 0.00 | 589.21K | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 1.55M | SH | $28.09M 5.50% | 0.00 | 1.55M | 0.00 |
RAPT THERAPEUTICS INCDFND | COM | 1.47M | SH | $27.40M 5.36% | 0.00 | 1.47M | 0.00 |
POINT BIOPHARMA GLOBAL INCDFND | COM | 3M | SH | $27.18M 5.32% | 0.00 | 3M | 0.00 |
ZURA BIO LTDDFND | CLASS A ORD SHS | 3.29M | SH | $27.02M 5.29% | 0.00 | 3.29M | 0.00 |
ACLARIS THERAPEUTICS INCDFND | COM | 2.20M | SH | $22.78M 4.46% | 0.00 | 2.20M | 0.00 |
AMYLYX PHARMACEUTICALS INCDFND | COM | 968.79K | SH | $20.90M 4.09% | 0.00 | 968.79K | 0.00 |
XENON PHARMACEUTICALS INCDFND | COM | 532.70K | SH | $20.51M 4.01% | 0.00 | 532.70K | 0.00 |
CYTOKINETICS INCDFND | COM NEW | 600K | SH | $19.57M 3.83% | 0.00 | 600K | 0.00 |
ANAPTYSBIO INCDFND | COM | 894.33K | SH | $18.19M 3.56% | 0.00 | 894.33K | 0.00 |
IMMUNOCORE HLDGS PLCDFND | ADS | 297.08K | SH | $17.81M 3.49% | 0.00 | 297.08K | 0.00 |
EVOLUS INCDFND | COM | 2.43M | SH | $17.70M 3.46% | 0.00 | 2.43M | 0.00 |
AEROVATE THERAPEUTICS INCDFND | COM | 932.16K | SH | $15.99M 3.13% | 0.00 | 932.16K | 0.00 |
SAREPTA THERAPEUTICS INCDFND | COM | 123.60K | SH | $14.15M 2.77% | 0.00 | 123.60K | 0.00 |
ALKERMES PLCDFND | SHS | 411.45K | SH | $12.88M 2.52% | 0.00 | 411.45K | 0.00 |
RHYTHM PHARMACEUTICALS INCDFND | COM | 772K | SH | $12.73M 2.49% | 0.00 | 772K | 0.00 |
OPTINOSE INCDFND | COM | 8.84M | SH | $10.87M 2.13% | 0.00 | 8.84M | 0.00 |
VIKING THERAPEUTICS INCDFND | COM | 598.55K | SH | $9.70M 1.90% | 0.00 | 598.55K | 0.00 |
MINERALYS THERAPEUTICS INCDFND | COM | 546.06K | SH | $9.31M 1.82% | 0.00 | 546.06K | 0.00 |
AMICUS THERAPEUTICS INCDFND | COM | 701.39K | SH | $8.81M 1.72% | 0.00 | 701.39K | 0.00 |
GRACELL BIOTECHNOLOGIES INCDFND | SPONSORED ADS | 2.27M | SH | $8.64M 1.69% | 0.00 | 2.27M | 0.00 |
APELLIS PHARMACEUTICALS INCDFND | COM | 94.70K | SH | $8.63M 1.69% | 0.00 | 94.70K | 0.00 |
RENEO PHARMACEUTICALS INCDFND | COM | 1.08M | SH | $7.11M 1.39% | 0.00 | 1.08M | 0.00 |
Page 1 of 2